The Cdx1 homeobox gene encodes an intestine-specific transcription factor with a pro-oncogenic function in vitro.
Introduction
Colon cancer is a multistep process in which a precursor lesion, the adenomatous polyp, evolves into a carcinoma. Initiation and progression of cancer result from the stepwise accumulation of genetic alterations leading to inactivation or loss of expression of tumour-suppressor genes, and to constitutive activation or overexpression of proto-oncogenes (Chung, 2000) . Many of these genes encode components of signalling pathways including APC, b-catenin, K-Ras, p53, TGFb receptors and Smads. Their downstream targets remain poorly understood; thus a number of genes involved in colon cancer are still to be identified.
The Cdx1 homeobox gene encodes a transcription factor selectively expressed in the intestinal epithelium (reviewed in Freund et al., 1998) . In the colon, its expression is confined in the crypts including the proliferating zone, as opposed to the surface epithelium made of differentiated epithelial cells (Silberg et al., 1997; Subramanian et al., 1998) . Studies in cell lines indicate that Cdx1 has a role in the control of gut homeostasis. Indeed, Cdx1 induction speeds up the proliferation of intestinal cells in culture (Soubeyran et al., 1999) , while its inhibition by antisense RNA reduces the growth of colon cancer cells (Lorentz et al., 1997) . The proliferating effect of Cdx1 is linked to the upregulation of the proliferating cell nuclear antigen (Oh et al., 2002) and the autocrine growth factor PAP-1 (Moucadel et al., 2001) , together with the downregulation of the cdk inhibitor p21WAF (Moucadel et al., 2002) . Forced expression of Cdx1 also stimulates cell differentiation at confluency (Soubeyran et al., 1999; Lynch et al., 2000) .
It is worth noting that, besides its role in gut homeostasis, Cdx1 regulates the Rho, Ras and PI3-kinase pathways, leading to transformation and tumorigenesis of intestinal epithelial cells, as assessed by anchorage-independent growth in soft agar and by tumour development in engrafted nude mice . Ectopic expression of Cdx1 also transforms marine fibroblasts (Maulbecker and Gruss, 1993) . The transforming effect of Cdx1 led to attribute a prooncogenic potential to this homeobox gene. This is in line with the fact that Cdx1 is a target of two major oncogenic pathways, the b-catenin pathway and the Ras pathway, in colon cancer cell lines (Lorentz et al., 1999; Lickert et al., 2000; Domon-Dell and Freund, 2002) . Moreover, an ectopic expression of Cdx1 has been reported in adenomas outside the gut: in the stomach, oesophagus and liver (Silberg et al., 1997; Ren et al., 2000) . However, we and others have shown that the level of Cdx1 expression is decreased in the majority of human colon carcinomas (Mallo et al., 1997; Silberg et al., 1997; Vider et al., 1997) . These paradoxical observations prompted us to analyse the pattern of Cdx1 during human colon cancer progression.
Material and methods

Tissue collection
Human intestinal polyps and normal adjacent mucosa located 5 cm away were collected during routine endoscopy examination. Colon tumours and liver metastases were obtained from surgical specimens at the Department of Visceral Surgery (Hoˆpitaux Universitaires de Strasbourg), under the institutional review of the French ethics committee. Patients were distributed as stages A-D according to the Astler-Coller classification. For each patient, 5 ml of blood was collected in 15% EDTA. Tumour fragments were assessed by histopathology to contain more than 50% of cancer cells.
Human tumour xenografts
Fresh tumour tissues from primary colon carcinomas were obtained as described above and aseptically transferred into a sterile tube containing DMEM supplemented with 200 UI/ml penicillin, 200 mg/ml streptomycin, 40 mg/ml gentamicin and 5 mg/ml fungizone (Gibco Life Technologies). After removal of fibrotic and necrotic portions, the remaining cancerous tissue was divided into small pieces, approximately 1 mm diameter, and washed twice with the abovementioned antibiotic-containing medium. Tissue fragments were further minced with scissors and finally triturated through an 18-gauge needle before injection in nude (nu/nu) mice.
Nude mice (6-8-week old) were purchased from Iffa Credo (Charles River Laboratories) and maintained under pathogen-free conditions. Mice were anaesthetized with isoflurane (Forane s , Abbott) inhalation and 0.4 ml of tumour tissue preparation was injected subcutaneously on both sides into the dorsum. After transplantation, the xenografts were resected when their volume reached approximately 1000 mm 3 (usually 3 months after injection). Collected xenografts were divided into two pieces. One piece was instantly frozen in liquid nitrogen and stored at À801C. The remaining xenograft portion was processed as previously described for the primary tumour and inoculated into another nude mouse in order to maintain the growth of human tumour xenografts by serial passages.
RNA extraction and RT-PCR analysis
Tissue samples in RNA Later solution (Ambion) were used to extract RNA with Tri-Reagent (MRC). Cdx1 RNA level was analysed by semiquantitative RT-PCR, as previously described (Lorentz et al., 1997) , using the primers: HCDX1a, GCGCAGAGGCCGACGCCCTA-CGAGT and HCDX1b, and b-actin RNAs were analysed using the primers: HCK19a, TTGAGATTGAGCTGCAGTCCCAGCT/ HCK19b, CCCTCGAGCAGGCTGCGGTAGGTGGC, and HACTa, TCGTGCGTGACATTAAGG/HACTb, CGAAAGCAATGCTATCAC. PCR was performed for 28-36 cycles, and the products were run on 3% agarose gels and analysed using an Imaging Densitometer (GelDoc 1000, Bio-Rad). RT-PCR analysis was repeated at least three times for each sample.
DNA extraction and analysis of allelic imbalance
Genomic DNA was extracted from frozen tissue and blood, and microsatellite DNA was analysed on pairs of blood vs tumours or normal adjacent mucosa vs tumour tissue as described previously (Schneider et al., 2000a, b; Weber et al., 2001) . The microsatellite markers used in this study are listed in Table 1 , and the primers used for PCR amplification were those recommended in the genome database (http://www.gdb.org). For PCR, one primer in each pair was 5 0 Cy5-labelled. The amplified PCR fragments were separated by electrophoresis on an ALF-sequencer and directly analysed for allelic imbalance (AI) using the Allelink software package (Amersham Pharmacia), and for microsatellite instability (MSI) characterized by the presence of extra PCR fragments in tumour DNA compared to control blood DNA. AI frequency at a given locus indicates the proportion of specimens among the present collection, which exhibit allelic imbalance at this locus. AI intensity in a single sample indicates the difference between the two alleles at the locus, compared to normal adjacent mucosa or blood. AI intensity, thought to represent the proportion of rearranged cells in the sample, was determined as described (Schneider et al., 2000a, b; Weber et al., 2001) . Cdx1 in human colon cancer C Domon-Dell et al
Antibody production and immunohistochemistry
Rabbits were immunized by repeated injections of the peptide CATSSPMPVKEEFLP coupled to KLH, which corresponds to the carboxy end of the human CDX1 protein. The specificity of the antiserum was demonstrated by Western blotting (not shown). Antibodies were selected by immunoaffinity using the peptide coupled to a Sulfo-link column (Pearce). Tissue samples were fixed in 4% paraformaldehyde and embedded in paraffin. Sections (6 mm) were deparaffinized and antigens were retrieved by heating twice for 5 min in 10 mm citrate (pH 6) using a microwave (700 W). The sections were blocked in PBS, 0.1% Triton X-100 and 5% normal goat serum, and incubated overnight at 41C with the anti-CDX1 antibody. Secondary biotinylated antirabbit antibody was revealed using the Vectastain ABC Elite kit (Vector Laboratories Inc.).
Results
Cdx1 allelic imbalance in colon carcinomas and polyps
Several reports including our own data have shown that the expression of Cdx1 is reduced or even lost in the majority of colon carcinomas (Mallo et al., 1997; Silberg et al., 1997; Vider et al., 1997) . This prompted us to investigate whether this locus is a hotspot for genomic rearrangement. For this purpose, 169 human colon carcinomas were analysed for allelic imbalance at the level of two microsatellite markers flanking the Cdx1 locus, D5S413 and D5S2013 (Table 1) . D5S2013 maps very close to the Cdx1 gene, at 19-kb downstream of the transcription unit. Based on a previous study that we had conducted in a series of 102 human colon tumours (Weber et al., 2001) , the rate of allelic imbalance was determined in parallel at the level of four microsatellilte markers located close to the genes encoding APC, p53, INK4 and Bcl2 (Table 1 ). Figure 1 illustrates the pattern in a single patient and Table 2 (upper panel) summarizes the results in the whole series of 169 carcinomas. Allelic imbalance was, respectively, observed in 54% (53/99) and 52% (47/90) of the informative cases for D5S2013 and D5S413, and imbalance for both markers in a single sample was found in 48% (19/40) of the cases. Thus, genomic rearrangement at the Cdx1 locus is a frequent event in colon carcinomas. Compared to Cdx1, the D5S346 marker close to APC showed a higher rate of allelic imbalance with 57% (77/135) of the informative cases. With a single exception (see below the specimen Figure 1 Allelic imbalance pattern in a patient with colon carcinoma and liver metastasis. Allelic imbalance was analysed in one patient (specimens 17a and 17b in Table 3 ) for the markers D5S346 (close to APC), D5S2013 (telomeric to Cdx1). D5S413 (centromeric to Cdx1), D18S61 (close to Bcl2), TP53 and D9S171 (close to INK4). Analyses were performed on genomic DNA extracted from the blood (B), from the carcinoma (C), from the adjacent normal colonic mucosa (N) and from the liver metastases (M). Amplified PCR fragments were separated by electrophoresis and the amount of each fragment was determined by direct fluorometric measurement.
Note that blood DNA and DNA from the normal colonic mucosa always exhibited the same pattern. Arrows indicate the cases of allelic imbalance in tumour and metastatic tissues, as compared to normal mucosa or blood Cdx1 in human colon cancer C Domon-Dell et al 6c), we found that all the specimens rearranged at the level of Cdx1 markers also exhibited rearrangement of the APC marker. Allelic imbalance at the D18S61, TP53 and D9S171 microsatellite markers close to the Bcl2, p53 and INK4 genes was observed in, respectively, 68% (84/129), 66% (87/131) and 34% (39/114) of the carcinomas.
Since the metastatic process is thought to be associated with the accumulation of additional genomic alterations compared to primary tumours, we have repeated this analysis in a series of 55 colon liver metastases (Table 2 , middle panel). Consistent with the general progression of allelic imbalance observed with tumour grade (Weber et al., 2001) , we found an increasing rate of allelic imbalance in metastases compared to colon carcinomas for the markers close to p53, Bcl2 and INK4. However, the value for the marker close to APC was similar in metastases and in carcinomas, as shown previously (Weber et al., 2001) , and the same was also observed for the two markers flanking the Cdx1 gene.
The high rate of genomic rearrangement found at the Cdx1 locus in carcinomas led us to analyse the pattern of this gene in colon polyps using a consecutive series of 85 samples. The results are summarized in Table 2 (lower panel). Allelic imbalance was respectively detected in 29% (17/58) and in 24% (11/46), respectively, of the informative cases for the markers D5S2013 and D5S413 flanking the Cdx1 gene, and allelic imbalance for both markers in the same specimen occurred in 29% (7/24) of the cases. Thus, rearrangement at the Cdx1 locus can already be detected in some colon polyps, yet less frequently than in carcinomas (29 vs 48%). Allelic imbalance at the level of the D5S346 marker close to APC was very frequent in polyps (40%), corroborating the prime importance of this gene in colon tumour initiation, whereas the rates of allelic imbalance at the microsatellite markers close to Bcl2, p53 and INK4 were much lower than those measured in carcinomas.
Genomic rearrangements along the APC-to-Cdx1 region
The Cdx1 gene lies on chromosome arm 5q at position 31-33 (Bonner et al., 1995) , at a distance of approximately 35 cM of APC located in 5q21-22. Since the above results indicate that both loci are subjected to genomic rearrangement during colon tumour progression, we have investigated if there is a relation between the two events. To this end, we have performed an allelic imbalance analysis including 11 microsatellite markers scattered along the APC-to-Cdx1 region of chromosome 5q (Table 1) , in a series of 40 samples selected in the above collection of polyps, carcinomas and metastases on the basis of their specific pattern of genomic alterations at the level of APC and Cdx1. The results are summarized in Table 3 .
The first group, comprising eight polyps and two carcinomas, was characterized by the absence of allelic imbalance at the level of the microsatellite markers close to APC and Cdx1. In this group, no allelic imbalance was found at any of the microsatellite markers scattered along the APC-to-Cdx1 region. The presence of cancer cells in these lesions was assessed by the genomic alterations in loci outside chromosome 5. Thus, these tumour lesions develop without chromosome rearrangement throughout the APC-Cdx1 region.
Contrasting with the first group, the second group included eight polyps, eight carcinomas and six liver metastases with allelic imbalance (or homozygosity) at the level of the two Cdx1 and APC loci. In this group, allelic imbalance (or homozygosity) was obvious for every microsatellite marker along the APC-Cdx1 region, indicating that these specimens exhibit major Results are given as percentages of the number of specimens (n) in each group. Homozygotes were excluded for percentage calculation of AI because they are not informative for this type of analysis. For each marker, parentheses give the number of patients with allelic imbalance among the informative cases (those that do not exhibit homozygosity). AI: allelic imbalance; MSI: microsatellite instability; h: homozygosity. The D5S2013 and D5S413 markers are, respectively, located at the telomeric and centromeric side of Cdx1
Cdx1 in human colon cancer C Domon-Dell et al genomic rearrangements encompassing the entire APCto-Cdx1 region of chromosome arm 5q. The third group of two polyps and five carcinomas corresponded to specimens with allelic imbalance at the level of the microsatellite marker close to APC, but no imbalance at the level of the two markers flanking the Cdx1 locus. Strikingly, allelic imbalance analysis of the microsatellite markers scattered along the APC-Cdx1 region revealed that the markers adjacent to the APC locus were rearranged up to a breakpoint located within the APC-Cdx1 inter-region, whereas the markers downstream to the breakpoint in the centromeric direction (including Cdx1) were not rearranged. The seven samples of this group identified four different breakpoints.
Finally, specimen 6c, a mucous-secreting carcinoma, presented a unique pattern within the whole series of samples analysed in this study, because allelic imbalance was detected only at the level of a small segment comprising the Cdx1 locus. Unlike the specimens of the second group, this sample was not rearranged at the level of the microsatellite markers in the more telomeric and centromic directions, including the APC locus.
To address whether the genomic rearrangements described here at the level of the APC-Cdx1 region of chromosome arm 5q are associated with a complete loss of this chromosome, we have analysed 20 samples of the above series for allelic imbalance at the level of the marker D5S430 located on chromosome arm 5p. As shown in Table 3 , allelic imbalance was independent on both arms, since several specimens rearranged along the whole APC-to-Cdx1 region did not exhibit allelic imbalance for the D5S430 marker on chromosome arm 5p, whereas other samples showed allelic imbalance at the level of the microsatellite markers located on both q and p arms of chromosome 5.
Together, these results indicate that the rearrangements at the Cdx1 locus on chromosome 5q are related to, although not invariably associated with, those occurring at the APC locus on the same chromosome arm. The genomic site of the rearrangements would include primarily APC and extends towards the Cdx1 direction. Only rare specimens (one case in this study) are rearranged at the level of Cdx1 when APC remains intact.
Cdx1 expression in colon polyps
Cdx1 expression increases from the proximal to the distal part of the colon in humans (data not shown), as already reported in rodents (James et al., 1994; Silberg et al., 2000) . We have analysed the expression of the Cdx1 mRNA in a series of 19 colon polyps and in the normal adjacent mucosa obtained during routine endoscopy. Normalization used the epithelial-specific mRNAs for cytokeratin-19 or b-actin. Five out of the 19 patients in this series also exhibited a carcinoma at a distance from the polyp. All the polyps were adenomatous with weak to moderate dysplasia. Figure 2A illustrates examples of these results. In 42% (8/19) of the polyps, the Cdx1 mRNA level was unchanged as compared to the normal adjacent mucosa (see patients 1 and 2). However, the amount of Cdx1 mRNA was increased in 37% (7/19) of the polyps (illustrated in patients 7-10 and 16). On the contrary, it was decreased in 21% (4/19) of the polyps (patients 12, 13 and 18). As expected from previous data (Mallo et al., 1997; Silberg et al., 1997; Vider et al., 1997) , Cdx1 mRNA expression became undetectable in all the five carcinomas tested in this series (see for example, panels 16 and 18).
Next, we have established the status of the Cdx1 genomic locus in these samples, and the data are summarized in Table 4 . Owing to the small amount of material, data were obtained only for 11 among the 19 polyps. In the four specimens characterized by unchanged Cdx1 mRNA levels (specimens 1, 2, 3 and 15P), no allelic imbalance was found for the microsatellite markers close to Cdx1. In the four polyps with increased Cdx1 expression (specimens 7, 8, 17P and 18P), we also failed to detect any rearrangement at the level of Cdx1. Finally, among the three polyps exhibiting decreased expression of Cdx1, two were rearranged at the level of the Cdx1 locus (specimens 12 and 13), but not the third one (specimen 19P). In the carcinomas resected at a distance from the polyps, two of them exhibited allelic imbalance at the level of the Cdx1 microsatellite markers (specimens 17C and 19C), whereas the Cdx1 locus was not rearranged in the other two (specimens 15C and 18C). Beyond the Cdx1 locus, we have also analysed allelic imbalance for the marker close to APC (Table 4) and the results were consistent with those obtained in the large series of polyps, carcinomas and metastases shown in Table 3 . Interestingly, two polyps without allelic imbalance at the Cdx1 locus, but increased expression of the Cdx1 mRNA, were rearranged at the level of the APC locus (specimens 7 and 8).
We have then determined by immunohistochemistry the distribution of the CDX1 protein in the polyps showing increasing expression of Cdx1 mRNA. In these polyps, we found intense CDX1 staining even in the nuclei of the surface epithelium (Figure 2Ba ), unlike the situation in the normal mucosa. An intense staining was also observed in glandular and tubular structures characterizing adenomatous structures (Figure 2Bb) . Interestingly, several polyps showed heterogeneous cellular expression of CDX1, with some epithelial structures exhibiting a high nuclear staining of CDX1, while adjacent structures were devoid of this protein (Figure 2Bc ).
Xenografs of human colon tumours
To look for the relation between allelic imbalance at the Cdx1 locus and the expression of the gene, we have established and propagated human primary colon tumours as xenografts by serial transplantation in nude mice. Figure 3 illustrates the data obtained for three series of xenografts. The primary tumours were carcinomas of stages C and D according to Astler-Coller. The first primary tumour (series 1) was characteristic of group 1 described in Table 3 with no allelic imbalance at Cdx1 in human colon cancer C Domon-Dell et al the level of the microsatellite markers close to both APC and Cdx1. In this series, Cdx1 was actively transcribed in the tumour like in the normal adjacent mucosa. The transplantable xenograft derived from this tumour remained without genomic rearrangement along the APC-Cdx1 region, and consistently, the Cdx1 mRNA remained as abundant in the xenograft as in the normal mucosa and in the primary tumour. Unlike series 1, the xenografts of series 2 and 3 are derived from tumours showing allelic imbalance at the level of the microsatellite markers close to both APC and Cdx1 loci, as those classified in group 2 in Table 3 . In these primary tumours, Cdx1 mRNA was still expressed, although at a lower level than in the adjacent normal mucosa. Strikingly, the xenografts derived from these tumours showed a very low or even undetectable expression of Cdx1 mRNA in comparison to the normal mucosa and the primary tumours, In line with this, the intensity of allelic imbalance of the markers of the APC and Cdx1 loci, thought to reflect the proportion of tumour cells compared to nontransformed cells within the samples, was relatively low (40-60%) in the primary tumours that still expressed Cdx1 mRNA, whereas it increased to 80-90% in the xenografts that lost mRNA expression. 
Allelic imbalance was determined at the level of 11 microsatellite markers along the APC-to-Cdx1 region on chromosome arm 5q and at the level of the microsatellite D5S430 on chromosome arm 5p. Samples are polyps (P), carcinomas (C) and metastases (M) from 18 patients (1-18) in which different specimens were analysed (a-e). AI: allelic imbalance; MSI: microsatellite instability; 0: no allelic imbalance; h: homozygosity; nd: not defined; -not analysed. Grey boxes indicate genomic alterations (either AI or MSI); white regions denote no genomic rearrangement Cdx1 in human colon cancer C Domon-Dell et al
Taken together, these results indicate that the decline of Cdx1 mRNA correlates with the intensity of allelic imbalance at the Cdx1 locus.
Discussion
In this study, we show a complex pattern of Cdx1 during the progression of colon cancer. First, a high amount of Cdx1 mRNA and protein is retained in the majority of the polyps and it is even upregulated in one-third of the specimens, whereas downexpression occurs in one-fifth of the cases. However, in the carcinomas analysed here, we found a loss of expression, which is consistent with our previous findings and with the data in the literature (Mallo et al., 1997; Silberg et al., 1997; Vider et al., 1997) . Second, the genomic analysis by allelic imbalance , and also in carcinomas (C) located at a distance from the polyps. The level of Cdx1 mRNA was unchanged in specimens 1 and 2 compared to the normal tissue. In polyps 7-10 and 16, the level of Cdx1 mRNA was increased compared to the adjacent normal mucosa, whereas it was decreased in specimens 12, 13 and 18. In the two carcinoma illustrated here (16 and 
Allelic imbalance of the microsatellite markers close to Cdx1 and APC was determined in polyps (P) and carcinomas (C) analysed for Cdx1 mRNA expression (the numbering of the specimens corresponds to those in Figure 2) . The Cdx1 mRNA level was unchanged ( ¼ ), decreased (À) or increased (+) in specimens as compared to the adjacent normal colonic mucosa. AI: allelic imbalance; 0: no allelic imbalance; h: homozygosity; MSI: microsatellite instability; nd: not defined Cdx1 in human colon cancer C Domon-Dell et al determination reveals that the Cdx1 locus located on chromosomal arm 5q is a hotspot for genomic rearrangements and that the frequency of alterations at this locus increases during the progression from polyps to carcinomas. The rearrangements at the Cdx1 locus are related to, although not invariably associated to, those occurring at the level of the APC locus located on the same chromosomal arm. The elevated expression of Cdx1 reported here in a number of polyps suggests that this homeobox gene may actively participate in early progression of human colon cancers, since Cdx1 has been shown to induce intestinal cell transformation and tumorigenesis . The transformation effect is linked to the Cdx1-dependent activation of the Ras, Rho and PI3 K pathways, while Cdx1 also stimulates cell proliferation and resistance to apoptosis via its opposite regulatory role in the expression of the cell cycle inhibitor p21WAF and of the antiapoptotic molecule Bcl2 (Lorentz et al., 1997; Soubeyran et al., 1999 Soubeyran et al., , 2001 Moucadel et al., 2002) . The elevated expression of Cdx1 observed in a high number of polyps is consistent with the fact that this homeobox gene is a target of oncogenic pathways that are early and frequently activated in colon cancers, like the APC/b-catenin and the Ras pathways (Lorentz et al., 1999; Lickert et al., 2000; Domon-Dell and Freund, 2002) . Indeed, in this study, we have identified several specimens in which the overexpression of Cdx1 correlates with genomic rearrangements at the level of APC, while the Cdx1 locus remains intact. Also worth noting is the expression of Cdx1 shown here up to the surface epithelium in polyps, which is reminiscent of the oncogenic activation of the APC/b-catenin pathway reported at the top of the epithelium in microadenomas (Shih et al., 2001) . The high expression of Cdx1 observed in human polyps compared to normal adjacent mucosa is often associated with tubular adenomatous epithelial structures; this is in line with our recent observation of elevated Cdx1 expression in the adenomatous regions of colon cancerous lesions that develop experimentally after treatment with a chemical mutagen in mice haplo-insufficient for the Cdx2 homeobox gene (manuscript submitted for publication). In the present study, we found that the stimulation of Cdx1 is the most effective in specimens in which the normal level of expression in the adjacent mucosa is relatively low. In humans, the expression of Cdx1 mRNA increases from the proximal to the distal end of the colon (data not shown), as already reported in mice (James et al., 1994; Silberg et al., 2000) . Thus, it is likely that the actual level of Cdx1 expression in the polyps, and therefore the impact of this homeobox gene on tumorigenesis, may depend on both the location of the tumour in the colon, and on the rate of activation of oncogenic pathway(s).
Unlike polyps, the majority of the colon carcinomas are characterized by a reduction of Cdx1 expression (Mallo et al., 1997; Silberg et al., 1997; Vider et al., 1997) . Here we show that this decrease is connected to highly frequent genomic rearrangements at the level of the Cdx1 locus located on chromosome arm 5q. Indeed, the frequency of allelic imbalance at this locus increases during polyp to carcinoma progression, and all the samples with allelic imbalance, which were analysed for mRNA content, also showed a decrease of Cdx1 expression. Moreover, the data of xenografts of primary colon tumours in nude mice strongly suggest that the rate of mRNA reduction increases with the intensity of allelic imbalance. Using a series of microsatellite markers on chromosome 5q, we found that the rearrangements at the Cdx1 locus are most frequently associated to allelic imbalance at the APC locus on the same chromosome arm, while a small proportion of samples exhibit allelic imbalance at the APC locus without rearrangement of Cdx1. The reverse situation, namely specific allelic imbalance encompassing the Cdx1 gene without rearrangement at the level of APC, is very rare since it was observed in only one case over more than 300 specimens analysed in this study. Thus, genomic alterations primarily target the region of the APC gene in colon cancers and they can extend along a large portion of chromosome arm 5q up to the Cdx1 gene located 35 cM away. According to common data in the literature, further analysis of the genomic alterations in these tumours led us to demonstrate that allelic imbalance at the APC locus is associated to mutations of the second allele giving rise to truncated proteins (data not shown). In this study, we have not addressed if an additional mechanism of allelic imbalance can concur to account for complete loss of expression of Cdx1. Yet, hypermethylation of the Cdx1 promoter has been recently reported in human colon cancer cell lines (Suh et al., 2002) , suggesting an alternative way to reduce the expression of this homeobox gene in tumours. Such a mechanism could also participate in reducing the expression of Cdx1 in some specimens lacking allelic imbalance at this locus. Taken together, these data suggest that the maintenance of a high level of Cdx1 expression is dispensable for carcinoma progression. Whether this decline facilitates carcinoma evolution is an open question, although it seems unlikely because Cdx1 deficiency has not been associated with tumour development in mice (Subramanian et al., 1998) . Importantly, the APC-Cdx1 region, which is frequently rearranged throughout its length in colon cancers, comprises a number of genes (a-catenin, protein phosphatase 2, TGFb1, cdc23, cdc25C, ubiquitin-conjugating enzyme E2D2, histone deacetylase 3), the alteration of which may also participate in the malignant behaviour of tumour cells.
In conclusion, Cdx1 exhibits a complex pattern during colon tumour progression, with a high and elevated expression in the majority of the polyps, and a progressively reduced expression associated with genomic rearrangements in few polyps and in a great proportion of carcinomas. In line with this complex pattern, immunohistochemistry revealed the glandular heterogeneity of Cdx1 expression already in polyps. The transforming function of Cdx1 and its effect on cell proliferation and on resistance to apoptosis suggest that its upregulation is a component of the process toward malignant evolution during the first steps of tumorigenCdx1 in human colon cancer C Domon-Dell et al esis. Transgenic models will address the pro-oncogenic potential of Cdx1 in vivo. The present findings in colon samples are reminiscent of data reported in pathological cases in the oesophagus, stomach and liver, when ectopic expression of Cdx1 occurs in a subset of adenomas, while the expression declines in more advanced tumours (Silberg et al., 1997; Ren et al., 2000) . Further studies are required to determine if in these latter cases, ectopic expression of Cdx1 is linked to the activation of oncogenic pathways, and if the locus is also subjected to genomic rearrangements in later stages of tumour progression.
